Karah Herdman Parschauer is a director of Tenaya Therapeutics Inc.
Person profile
Roles
Address
Novato, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ultragenyx Pharmaceutical Inc.
5 Mar 24
4
Evolus, Inc.
9 Feb 24
4
Evolus, Inc.
2 Feb 24
144
Evolus, Inc.
30 Jan 24
4
Tenaya Therapeutics, Inc.
12 Jun 23
4
Ultragenyx Pharmaceutical Inc.
5 May 23
144
Ultragenyx Pharmaceutical Inc.
4 May 23
4
Ultragenyx Pharmaceutical Inc.
3 Mar 23
4
Evolus, Inc.
31 Jan 23
4
Anebulo Pharmaceuticals, Inc.
3 Oct 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 53.76 | 3,756 | 201.92 k | 67,340 |
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 957 | 0.00 | 70,739 |
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 17,800 | 0.00 | 69,782 |
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 53.69 | 31,400 | 1.69 mm | 31,400 |
7 Feb 24 | EOLS Evolus | Common Stock | Grant | Acquire A | No | No | 0 | 6,464 | 0.00 | 37,707 |
7 Feb 24 | EOLS Evolus | Stock Option Common Stock | Grant | Acquire A | No | No | 13.15 | 9,377 | 123.31 k | 9,377 |
30 Jan 24 | EOLS Evolus | Common Stock | Sell | Dispose S | No | No | 13.1366 | 11,931 | 156.73 k | 31,243 |
9 Jun 23 | TNYA Tenaya Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.12 | 29,532 | 210.27 k | 29,532 |
4 May 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | Yes | 45 | 4,378 | 197.01 k | 51,982 |